Uncured aqueous composition comprising a blend of (a) a sulfonated polyester, (b) at least one of a self-crosslinking acrylic or a self-crosslinking polyurethane binder, and (c) melamine-formaldehyde crosslinker, wherein the uncured aqueous composition has a free-formaldehyde content not greater than 0.04 part per million formaldehyde as determined by the Formaldehyde Test, and cured composition thereof. Compositions described herein are useful, for example, for making primed film for release liners applications.

A preparation of an aqueous composition that is resistant to temperature variations may include the use of at least one specific heat-stabilizing agent. The heat stabilization of the viscosity of the aqueous composition within a wide temperature range. Such heat-stabilizing agents may include, in polymerized form: (a1) an anionic monomer comprising a polymerizable olefinic unsaturation and a carboxylic acid group, optionally in salt form; (a2) a C1-C7 ester of acrylic acid, methacrylic acid, maleic acid, and/or itaconic acid; (a3) an associative monomer of a formula, R.sup.1-(EO).sub.m-(PO).sub.n-R.sup.2, wherein m and n are independently 0 or an integer or decimal less than 150, m or n being different from 0, EO is independently a CH.sub.2CH.sub.2O group, PO is independently a combination of (i) CH.sub.2CH.sub.2O and (ii) CH(CH.sub.3)CH.sub.2O and/or CH.sub.2CH(CH.sub.3)O, R.sup.1 is independently a group comprising a polymerizable olefinic unsaturation, and R.sup.2 is independently a straight C.sub.28-C.sub.40-alkyl group or a C.sub.28-C.sub.40-alkyl group.

Artificial cartilage materials for repair and replacement of cartilage, such as load-bearing and articular cartilage. The artificial cartilage materials can include a hydrogel with an internal polymer support network that impart the hydrogel mechanical properties similar to that of natural cartilage. In some examples, the hydrogels include a cross-linked cellulose network and a double network of polyvinyl alcohol (PVA) and polyacrylamide-methyl propyl sulfonic acid (PAMPS) polymers. The hydrogels may include specific formulations of different polymers to impart mechanical properties that are within a cartilage equivalent range. The artificial cartilage materials may include a porous base that is bonded to the hydrogel for interfacing with surrounding tissues and promoting ingrowth of bone and/or cartilage. Thus, the materials may be well suited for forming a synthetic graft, such as an osteochondral graft, for implantation into a patient's body.

Artificial cartilage materials for repair and replacement of cartilage, such as load-bearing and articular cartilage. The artificial cartilage materials can include a hydrogel with an internal polymer support network that impart the hydrogel mechanical properties similar to that of natural cartilage. In some examples, the hydrogels include a cross-linked cellulose network and a double network of polyvinyl alcohol (PVA) and polyacrylamide-methyl propyl sulfonic acid (PAMPS) polymers. The hydrogels may include specific formulations of different polymers to impart mechanical properties that are within a cartilage equivalent range. The artificial cartilage materials may include a porous base that is bonded to the hydrogel for interfacing with surrounding tissues and promoting ingrowth of bone and/or cartilage. Thus, the materials may be well suited for forming a synthetic graft, such as an osteochondral graft, for implantation into a patient's body.

Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a subject (e.g., a patient) such that the residence structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before being released. The residence structure may be, in some cases, a gastric residence structure. In some embodiments, the structures and systems described herein comprise one or more materials configured for high levels of active substances (e.g., a therapeutic agent) loading, high active substance and/or structure stability in acidic environments, mechanical flexibility and strength in an internal orifice (e.g., gastric cavity), easy passage through the GI tract until delivery to at a desired internal orifice (e.g., gastric cavity), and/or rapid dissolution/degradation in a physiological environment (e.g., intestinal environment) and/or in response to a chemical stimulant (e.g., ingestion of a solution that induces rapid dissolution/degradation). In certain embodiments, the structure has a modular design, combining a material configured for controlled release of therapeutic, diagnostic, and/or enhancement agents with a structural material necessary for gastric residence but configured for controlled and/or tunable degradation/dissolution to determine the time at which retention shape integrity is lost and the structure passes out of the gastric cavity. For example, in certain embodiments, the residence structure comprises a first elastic component, a second component configured to release an active substance (e.g., a therapeutic agent), and, optionally, a linker. In some such embodiments, the linker may be configured to degrade such that the residence structure breaks apart and is released from the location internally of the subject after a predetermined amount of time.

Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a subject (e.g., a patient) such that the residence structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before being released. The residence structure may be, in some cases, a gastric residence structure. In some embodiments, the structures and systems described herein comprise one or more materials configured for high levels of active substances (e.g., a therapeutic agent) loading, high active substance and/or structure stability in acidic environments, mechanical flexibility and strength in an internal orifice (e.g., gastric cavity), easy passage through the GI tract until delivery to at a desired internal orifice (e.g., gastric cavity), and/or rapid dissolution/degradation in a physiological environment (e.g., intestinal environment) and/or in response to a chemical stimulant (e.g., ingestion of a solution that induces rapid dissolution/degradation). In certain embodiments, the structure has a modular design, combining a material configured for controlled release of therapeutic, diagnostic, and/or enhancement agents with a structural material necessary for gastric residence but configured for controlled and/or tunable degradation/dissolution to determine the time at which retention shape integrity is lost and the structure passes out of the gastric cavity. For example, in certain embodiments, the residence structure comprises a first elastic component, a second component configured to release an active substance (e.g., a therapeutic agent), and, optionally, a linker. In some such embodiments, the linker may be configured to degrade such that the residence structure breaks apart and is released from the location internally of the subject after a predetermined amount of time.

A pigment composition including at least one pigment selected from the group consisting of a perinone-based pigment and a perylene-based pigment, water, a resin having a constitutional unit represented by Formula 1, and at least one compound selected from the group consisting of a phthalimide compound having a carboxyalkyl group and a naphthalimide compound having a carboxyalkyl group; a method for producing thereof; and an aqueous ink composition using the pigment composition. In Formula 1, R.sup.1 represents a hydrogen atom or a methyl group, L.sup.2 represents —C(═O)O—, —OC(═O)—, or —C(═O)NR.sup.2— and R.sup.2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R.sup.3 represents an alkyl group having 6 or more carbon atoms. ##STR00001##

A pigment composition including at least one pigment selected from the group consisting of a perinone-based pigment and a perylene-based pigment, water, a resin having a constitutional unit represented by Formula 1, and at least one compound selected from the group consisting of a phthalimide compound having a carboxyalkyl group and a naphthalimide compound having a carboxyalkyl group; a method for producing thereof; and an aqueous ink composition using the pigment composition. In Formula 1, R.sup.1 represents a hydrogen atom or a methyl group, L.sup.2 represents —C(═O)O—, —OC(═O)—, or —C(═O)NR.sup.2— and R.sup.2 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R.sup.3 represents an alkyl group having 6 or more carbon atoms. ##STR00001##

An acrylic rubber contains a copolymer of a monomer mixture of: 25 to 46 wt. % of alkoxyalkyl acrylate, 23 to 37 wt. % of 2-ethylhexyl acrylate, 9 to 17 wt. % of alkyl methacrylate, 1 to 3 wt. % of monoalkyl fumarate and the remaining amount is ethyl acrylate. This acrylic rubber improves hydrolysis resistance by introducing a specific alkyl acrylic monomer with extremely low hydrolysis property i.e. low hydrophilicity, and at the same time satisfies all of oil resistance, cold resistance, and hydrolysis resistance in a well-balanced manner.

An acrylic rubber contains a copolymer of a monomer mixture of: 25 to 46 wt. % of alkoxyalkyl acrylate, 23 to 37 wt. % of 2-ethylhexyl acrylate, 9 to 17 wt. % of alkyl methacrylate, 1 to 3 wt. % of monoalkyl fumarate and the remaining amount is ethyl acrylate. This acrylic rubber improves hydrolysis resistance by introducing a specific alkyl acrylic monomer with extremely low hydrolysis property i.e. low hydrophilicity, and at the same time satisfies all of oil resistance, cold resistance, and hydrolysis resistance in a well-balanced manner.